US20030195553A1 - System and method for retaining vaso-occlusive devices within an aneurysm - Google Patents
System and method for retaining vaso-occlusive devices within an aneurysm Download PDFInfo
- Publication number
- US20030195553A1 US20030195553A1 US10/121,980 US12198002A US2003195553A1 US 20030195553 A1 US20030195553 A1 US 20030195553A1 US 12198002 A US12198002 A US 12198002A US 2003195553 A1 US2003195553 A1 US 2003195553A1
- Authority
- US
- United States
- Prior art keywords
- mesh
- vaso
- aneurysmal
- aneurysm
- occlusive device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
- A61B17/12113—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/12—Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B2017/1205—Introduction devices
- A61B2017/12054—Details concerning the detachment of the occluding device from the introduction device
- A61B2017/12063—Details concerning the detachment of the occluding device from the introduction device electrolytically detachable
Definitions
- the present invention relates generally to vaso-occlusion, and more particularly to systems and methods for retaining vaso-occlusive devices within an aneurysm.
- occlusive devices are useful in filling vascular or other body spaces.
- Some body spaces, such as vascular aneurysms, are formed due to a weakening in the wall of an artery. Often these aneurysms are the site of internal bleeding and stroke.
- embolic agents are known to be, at least ideally, suitable for treatment of these anomalies. These treatments are commonly known as “artificial vasoocclusion.”
- vaso-occlusive coils Implantable metal coils that are useful as artificial occlusion devices in vasculature lumens or aneurysms are herein referred to as “vaso-occlusive coils.”
- Vaso-occlusive coils are generally constructed of a wire, usually made of a metal or metal alloy that is wound to a helix. The vaso-occlusive coil assumes an irregular shape upon discharge of the device from the distal end of the catheter.
- a variety of vaso-occlusive coils are known. For instance, U.S. Pat. No.
- the coils may be used for small vessel sites, e.g., 0.5-6 mm in diameter.
- the coils themselves are described as being between 0.010 and 0.030 inches in diameter.
- the length of the coil wire is typically 15 to 20 times the diameter of the vessel to be occluded.
- the wire used to make up the coils may be, for instance, 0.002 to 0.006 inches in diameter.
- Tungsten, platinum, and gold threads or wires are said to be preferred.
- vaso-occlusive coils In addition to the various types of space filling mechanisms and geometries of vaso-occlusive coils, other particularized features of coil designs, such as mechanisms for delivering vaso-occlusive coils through delivery catheters and implanting them in a desired occlusion site, have also been described.
- the examples of categories of vaso-occlusive coils based upon their delivery mechanisms include pushable coils, mechanically detachable coils, and electrolytically detachable coils.
- Pushable coils are commonly provided in a cartridge and are pushed or “plunged” from the cartridge into a delivery catheter lumen. A pusher advances the pushable coil through and out of the delivery catheter lumen and into the site for occlusion.
- Mechanically detachable vaso-occlusive coils are typically integrated with a pusher rod and are mechanically detached from the distal end of that pusher after exiting a delivery catheter. Examples of such mechanically detachable vaso-occlusive coils are found in U.S. Pat. No. 5,261,916 to Engelson or U.S. Pat. No. 5,250,071 to Palermo.
- aneurysms present a particularly acute medical risk due to the dangers of potential rupture of the thin wall inherent in such aneurysms. Occlusion of aneurysms by use of vaso-occlusive coils without occluding the adjacent artery is a special challenge and is a desirable method of reducing such risk of rupture.
- These vaso-occlusive devices are typically placed in an aneurysm in a manner described in U.S. Pat. No. 4,739,768 issued to Engelson.
- a microcatheter is initially steered into or adjacent to the entrance of an aneurysm, typically aided by the use of a steerable guidewire. The wire is then withdrawn from the microcatheter lumen and replaced by the vaso-occlusive coil. The vaso-occlusive coil is advanced through and out of the microcatheter, desirably being completely delivered into the aneurysm.
- Aneurysm commonly known as a “wide neck aneurysm,” is known to present particular difficulty in the placement and retention of vaso-occlusive coils, because vaso-occlusive coils lacking substantial secondary shape strength may be difficult to maintain in position within an aneurysm no matter how skillfully they are placed.
- Wide neck aneurysms are herein referred to as aneurysms of vessel walls having a neck or “entrance zone” from the adjacent vessel, wherein the entrance zone has a diameter that either: (1) is at least 80% of the largest diameter of the aneurysm; or (2) is clinically observed to be too wide effectively to retain vaso-occlusive coils that are deployed using the techniques discussed above.
- U.S. Pat. No. 6,168,622 which describes a vaso-occlusive device with a secondary shape having a bulbous body portion and an anchor.
- the bulbous body portion is deployed within the aneurysm while the anchor is set just outside of the aneurysm, covering the aneurysm's neck or entrance zone.
- the device is integrally formed from a tube—clamped at both ends—of braided Nickel-Titanium (NiTi) wires.
- NiTi Nickel-Titanium
- vaso-occlusive coils it may still be desirable to deploy vaso-occlusive coils with such a device, but the bulbous body of the vaso-occlusive device does not provide much space within the aneurysm to allow for insertion and deployment of the coils.
- the present invention is directed to systems and methods for occluding an aneurysm having an aneurysmal neck and an aneurysmal inner wall.
- a device in accordance with the present invention includes a mesh-like structure that may be integrally composed of a shape-memory alloy such as NiTi.
- the device may be deployed within the aneurysm through the aneurysmal neck.
- the device may be configured to be in a deployed state and an undeployed state, and may be configured to transition from the undeployed state to the deployed state by exposure to a higher temperature and/or by being released from a compressive force.
- the device may function to retain finer vaso-occlusive devices such as vaso-occlusive coils and/or embolic liquids. Furthermore, the device itself may function as a vaso-occlusive device. The device may be delivered to the aneurysm by, e.g., a catheter.
- At least one of the proximal and distal ends of the mesh-like structure is configured to be inserted through the aneurysmal neck when in an undeployed state, and configured to flare open and expand against at least a portion of the aneurysmal inner wall when in a deployed state. Having a flared open end may advantageously allow the device to conform to the shape of the aneurysm.
- the distal end of the mesh-like structure may be configured to be inserted through the aneurysmal neck when in an undeployed state and configured to expand into a retainer against at least a portion of the aneurysmal inner wall when in a deployed state.
- the proximal end may be configured to expand into an anchor just outside of the aneurysm to secure the mesh-like structure in position.
- FIG. 1 is an illustration of a vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm;
- FIGS. 2 ( a ) and 2 ( b ) illustrate one preferred method of manufacturing the vaso-occlusive device of FIG. 1 in accordance with the present inventions
- FIG. 3 is an illustration of another vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm;
- FIG. 4 illustrates one preferred method of manufacturing the vaso-occlusive device of FIG. 3 in accordance with the present inventions
- FIG. 5 is an illustration of still another vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm;
- FIG. 6 illustrates one preferred method of manufacturing the vaso-occlusive device of FIG. 5 in accordance with the present inventions
- FIG. 7 is an illustration of still another vaso-occlusive device constructed in accordance with a preferred embodiment of the present inventions, wherein the vaso-occlusive device is shown fully deployed within an aneurysm;
- FIG. 8 illustrates one preferred method of manufacturing the vaso-occlusive device of FIG. 7 in accordance with the present inventions
- FIGS. 9 ( a )-( c ) illustrate a preferred method of delivering and deploying the vaso-occlusive device of FIG. 1 into the aneurysm;
- FIGS. 10 ( a )-( d ) illustrate a preferred method of delivering and deploying the vaso-occlusive device of FIG. 7 into the aneurysm
- FIGS. 11 ( a )-( c ) illustrate a preferred method of delivering and deploying the vaso-occlusive device of FIG. 5 into the aneurysm.
- a vaso-occlusive element 10 constructed in accordance with a preferred embodiment of the present invention is shown completely deployed within an aneurysm 40 of a blood vessel 60 .
- the aneurysm 40 is shown with an oppositely disposed neck 70 and dome 45 .
- the vaso-occlusive element 10 When deployed in its secondary shape, i.e., its deployed shape, the vaso-occlusive element 10 generally includes a central tubular element 15 and proximal 20 and distal 30 ends that are flared open into “umbrella” shapes. As illustrated, the flared opened ends 20 / 30 advantageously conform to the shape of the aneurysm 40 .
- the diameter of the proximal end 20 of the vaso-occlusive element 10 is larger than the neck 70 , and thus the proximal end 20 may completely cover the neck 70 .
- the vaso-occlusive element 10 is manufactured from a relatively dense braid.
- the proximal end 20 may densely cover the neck 70 and function as a retainer.
- finer vaso-occlusive devices such as vaso-occlusive coils or embolic liquids, may effectively be retained within the aneurysm 40 , or at the least, the likelihood of these devices migrating out from the aneurysm 40 is minimized.
- the relatively dense coverage of the proximal end 20 allows the vaso-occlusive element 10 itself to function as a vaso-occlusive device.
- the flared open distal end 30 is placed adjacent the dome 45 of the aneurysm 40 and allows the element 10 to safely conform to the shape of the dome 45 .
- the element 10 may conform to a large variety of shapes and sizes of aneurysms 40 since the element 10 need only be secured within the aneurysm 40 by conforming the flared open distal end 30 to the dome 45 .
- a braided tubular element 1 is constructed by braiding multiple fine wires 2 together.
- the tubular element 1 may also be formed of wires with varying diameters braided together. It may be desirable to use a larger number of wires 2 when forming the tubular element 1 , resulting in a relatively dense braid, which provides denser coverage within the aneurysm 40 .
- the tubular element 1 may be radiopaque.
- One method involves braiding a radiopaque fiber, such as platinum, Pt, or gold, Au, into the tubular element 1 .
- Another method involves plating or coating the tubular element 1 with radiopaque material. Additionally, one or more radiopaque markers may be added to the tubular element 1 .
- the wires 2 are made from a shape memory alloy, which can be of any type, but preferably is a “one way” trainable shape memory alloy.
- a preferable shape memory alloy for forming the braided tubular element 1 is Nickel-Titanium (NiTi)—e.g., 144 strands of 0.001′′ NiTi wires.
- NiTi Nickel-Titanium
- Shape memory alloys comprise a unique class of metal alloys that, once trained, are configured to “remember” a preselected shape, i.e., deployed shape, and can return to the preselected shape even if subsequently reshaped.
- the shape memory alloy is molded and heated at or above a training, or austenite, temperature to place the shape memory alloy in an austenite phase.
- the shape memory alloy is formed in the first preselected shape and then, once formed, is permitted to cool to a martensite finish temperature, whereupon the shape memory alloy enters a martensite phase.
- the martensite finish temperature can be any temperature that is less than the training temperature.
- the shape memory alloy has been trained to “remember” the first preselected shape. While in the martensite phase, the alloy is in a soft state and is formed into a second preselected shape, e.g., an undeployed shape.
- the shape memory alloy in the martensite phase is configured to maintain the second preselected shape and, if subsequently reheated to an activation temperature, automatically returns to the first preselected shape.
- the activation temperature can comprise any temperature that is greater than the martensite finish temperature and generally approximately equals the training temperature.
- the shape memory alloy is configured to maintain the first preselected shape irrespective of temperature.
- the training, martensite finishing, and activation temperatures for a shape memory alloy are adjustable, depending on the composition. For example, a slight extra amount of Nickel added to a NiTi alloy composition can change the training temperature from 0° C. to 100° C.
- the vaso-occlusive device 10 described above is delivered to the aneurysm 40 via a delivery catheter.
- the catheter delivers the device 10 to the aneurysm 40 and during the delivery, the device 10 maintains an undeployed shape, e.g., the original tubular shape—methods of delivery will be described in more detail below.
- the device 10 When the device 10 is deployed, the device 10 expands into its deployed shape, e.g., having flared open proximal and distal ends 20 / 30 , as shown in FIG. 1.
- Using a shape memory alloy to form the device 10 provides for alternative methods of expanding the device 10 into its deployed shape within the aneurysm 40 .
- One method involves configuring the device 10 to self-expand within the aneurysm 40 when deployed and exposed to the temperature of the aneurysm 40 .
- the training and activation temperatures are adjusted to be at, or just below, the temperature of the aneurysm, which is approximately 37° Celsius—the human body temperature.
- the martensite temperature is adjusted to be at a lower temperature. With these temperatures set, the device 10 is heated to, or above the training temperature—austenite phase—and shaped into its desired deployed shape, as described above.
- the temperature is lowered to, or below, the martensite finish temperature—martensite phase—and shaped into its desired undeployed shape.
- the device 10 is then placed inside the catheter as will be described below.
- the catheter can be constructed of a material that insulates the device 10 from the outside environment and maintains the temperature of the device 10 below the activation temperature.
- the device 10 does not expand into its deployed shape within the catheter.
- the temperature of the device will rise at or above the activation temperature, and the device 10 will expand into its deployed shape. Because the alloy is preferably “one way” trained, the device 10 will then be configured to maintain the deployed shape irrespective of the temperature, as described above.
- An alternative method for expanding the device 10 into its deployed shape within the aneurysm utilizes the super-elastic characteristic of shape memory alloys. After the device 10 is configured to maintain its deployed shape irrespective of the temperature, as described above, the device 10 is then maintained in its austenite phase. When the device 10 is in its austenite phase, the device 10 is super-elastic, i.e., the device 10 may be deformed to a certain degree and still be able to return to its deployed shape. The device 10 is then placed within the catheter as will be described below, with the inner wall of the catheter compressing the device 10 into its undeployed shape. When the device 10 is released out of the catheter into the aneurysm 40 , the uncompressed device 10 automatically expands into its deployed shape because of its super-elasticity.
- Forming the deployed shape shown in FIG. 1 is achieved by using two mandrels 85 , each having a cylindrical portion 90 and an umbrella dome-shaped mold 85 , as illustrated in FIG. 2( a ).
- two mandrels 85 each having a cylindrical portion 90 and an umbrella dome-shaped mold 85 , as illustrated in FIG. 2( a ).
- each end is placed over the cylindrical portion 90 of a mandrel 85 and compressed against the dome 85 , causing the ends to conform to the shape of the dome 85 and flare open.
- the assembly of the two mandrels 80 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase. The assembly is maintained at that temperature until the deployed shape has been formed.
- the assembly is cooled to, or below, the martensite finishing temperature to place the element 1 in the martensite phase.
- the mandrels 80 are removed from the element 1 , and the element 1 is formed into an undeployed shape, e.g., the original tubular shape. This may be achieved by placing the element 1 over a cylindrical mandrel 95 and compressing the flared ends to conform to the shape of the cylindrical mandrel 95 , as shown in FIG. 2 b .
- the element 1 may be reheated to the activation temperature, causing the element 1 to return to the deployed shape. Once the deployed shape has been recovered, the element 1 is configured to maintain the deployed shape irrespective of temperature.
- FIG. 3 another vaso-occlusive element 110 constructed in accordance with a preferred embodiment of the present invention is shown completely deployed within the aneurysm 40 .
- the vaso-occlusive element 110 when deployed, generally includes a central tubular element 115 and a flared distal end 130 .
- the vaso-occlusive element 110 further includes a proximal end 120 shaped as a flattened disk, which functions as a retainer.
- the proximal end 130 has a diameter larger than the diameter of the neck 70 , and thus completely covers the entrance zone 150 .
- the flattened disk 130 has a layer of braided wires on both sides, and thus may advantageously provide two layers of braided wires to cover the entrance zone 150 instead of one layer with the flared open proximal end 20 shown in FIG. 1.
- the flared open distal end 130 is placed adjacent the dome 45 of the aneurysm 40 and allows the element 110 to safely conform to the shape of the dome 45 .
- FIG. 4 one preferred method of manufacturing the vaso-occlusive device 110 shown in FIG. 3 will now be described.
- a braided tubular element 1 is first constructed. Forming the deployed shape is achieved by using one of the mandrels 85 shown in FIG. 2( a ) and the cylindrical mandrel shown in FIG. 2( b ), as illustrated in FIG. 4.
- the distal end is placed over the cylindrical portion 90 of the mandrel 85 with the dome 80 and compressed against the dome 80 , causing the distal end to flare open.
- the proximal end is placed on the cylindrical mandrel 95 .
- the proximal tip and a portion of the central tubular portion 115 are then compressed together along the axis of the cylindrical mandrel 95 . This causes the proximal end to expand into a flattened disk 120 .
- the assembly of the two mandrels 80 / 95 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase.
- the assembly is maintained at that temperature until the deployed shape 110 has been formed.
- the assembly is cooled to, or below, the martensite finishing temperature to place the element 110 in the martensite phase.
- the mandrels 80 / 95 are removed from the element 110 , and the element 110 is formed into an undeployed shape, e.g., the original tubular shape 1 . This is achieved by placing the element 110 over the cylindrical mandrel 95 and compressing the flared open end and flattened disk to conform to the shape of the cylindrical mandrel 95 , as shown in FIG.
- the element 1 is configured to expand into its deployed shape upon exposure to a higher temperature, then the element 1 may be placed within a delivery catheter in preparation for deployment, as described above. Alternatively, if the element 110 is configured to expand upon being released by a compressive force, then the element 1 is reheated to, or above, the activation temperature, causing the element 1 to return to the deployed shape 110 and to be configured to maintain the deployed shape 110 irrespective of temperature.
- FIG. 5 another vaso-occlusive element 210 constructed in accordance with a preferred embodiment of the present invention is shown deployed within the aneurysm 40 .
- the element 210 When in a deployed shape, the element 210 generally includes a central portion 215 and a distal end flared open into a “cup” shape 230 . Alternatively, the distal end may be flared open into a “cone” shape.
- the vaso-occlusive element 210 further includes a proximal end 220 shaped as a flattened disk. The proximal end 220 has a diameter larger than the diameter of the neck 70 .
- the cup shaped distal end 230 may retain fine vaso-occlusive devices such as vaso-occlusive coils and embolic liquids.
- a braided tubular element 1 is first constructed. Forming the deployed shape is achieved by using a mandrel 280 having a cup shaped dome 285 facing outward coupled to a cylindrical portion 290 and a cylindrical mandrel 95 . To form the cup shape, the distal end of the element 1 is placed over the cylindrical portion 290 of the mandrel 280 having the dome 285 and compressed against the dome 285 , causing the distal end to flare open into a cup shape. To form the flattened disk, the proximal end is placed over the cylindrical mandrel 95 . The proximal tip and a portion of the central tubular portion 215 are then compressed together along the axis of the cylindrical mandrel 95 . This causes the proximal end to expand into a flattened disk 220 .
- the assembly of the two mandrels 280 / 95 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase.
- the assembly is maintained at that temperature until the deployed shape 210 has been formed.
- the assembly is cooled to, or below, the martensite finishing temperature to place the element 210 in the martensite phase.
- the mandrels 280 / 95 are removed from the element 210 , and the element 210 is formed into an undeployed shape, e.g., the original tubular shape 1 .
- FIG. 7 another vaso-occlusive element 310 constructed in accordance with a preferred embodiment of the present invention is shown deployed within the aneurysm 40 .
- the element 310 When in a deployed shape, the element 310 generally includes a central portion 315 and first and second flattened disks 330 / 320 formed at the distal and proximal ends respectively. Only the first flattened disk 330 at the distal end is deployed within the aneurysm 40 whereas the second flattened disk 320 is deployed within the lumen 75 of the blood vessel 60 just outside of the aneurysm 40 , functioning as an anchor to secure the element 310 in its position.
- the first flattened disk 330 provides a wider coverage than the cup shape 230 shown in FIG. 5.
- this device 310 may also retain fine vaso-occlusive devices such as vaso-occlusive coils and embolic liquids.
- the central portion 315 may be conventionally sealed to prevent the fine vaso-occlusive devices from migrating out.
- a braided tubular element 1 is first constructed. Forming the deployed shape is achieved by using a cylindrical mandrel 95 , as illustrated in FIG. 8. To form the first flattened disk 330 , the distal end is placed on the cylindrical mandrel 95 . The distal tip and a portion of the central tubular portion 315 are then compressed together along the axis of the cylindrical mandrel 95 . This causes the distal end to expand into a flattened disk 330 . To form the second flattened disk 320 , the proximal end is placed on the cylindrical mandrel 95 . The proximal tip and a portion of the central tubular portion 315 are then compressed together along the axis of the cylindrical mandrel 95 . This causes the proximal end to expand into a flattened disk 320 .
- the assembly of the mandrel 95 and the element 1 is then heated at or above the training temperature to place the element 1 in the austenite phase.
- the assembly is maintained at that temperature until the deployed shape 310 has been formed.
- the assembly is cooled to, or below, the martensite finishing temperature to place the element 310 in the martensite phase.
- the mandrel 95 is removed from the element 310 , and the element 310 is formed into an undeployed shape, e.g., the original tubular shape 1 . This may be achieved by placing the element 310 over the cylindrical mandrel 95 and compressing the flattened disks 320 / 330 to conform to the shape of the cylindrical mandrel 95 , as shown in FIG.
- the element 1 is configured to expand into its deployed shape upon exposure to a higher temperature, then the element 1 may be placed within a delivery catheter in preparation for deployment, as described above. Alternatively, if the element 110 is configured to expand upon being released by a compressive force, then the element 1 is reheated to, or above, the activation temperature, causing the element 1 to return to the deployed shape 110 and to be configured to maintain the deployed shape 110 irrespective of temperature.
- the vaso-occlusive devices described above are delivered to an aneurysm within a blood vessel via a delivery catheter.
- FIGS. 9 ( a )-( c ) a method of deploying a vaso-occlusive device, and in this case the vaso-occlusive device 10 , to the aneurysm 40 via a delivery catheter 450 is illustrated.
- the catheter 450 is steered to just within the neck 70 of the aneurysm 40 .
- the vaso-occlusive device 10 is in its undeployed shape, and is coupled to an inner guidewire 465 via an electrolytically severable joint 455 .
- the assembly of the vaso-occlusive device 10 and the guidewire 465 extends through the lumen of the delivery catheter 450 such that the device 10 is positioned at the distal end of the catheter 450 .
- the guidewire 465 is then pushed toward the distal end of the catheter 450 causing the vaso-occlusive device 10 to extend out of the distal end of the catheter 450 , through the neck 70 , and into the aneurysm 40 .
- the portion of the device 10 that is free from the constraints of the catheter 450 expands into its deployed shape, e.g., the distal end 30 flares open.
- the device 10 may be configured to be in its martensite phase when delivered to the aneurysm 40 and expand upon exposure to the temperature of the aneurysm 40 .
- the temperature of the device 10 rises and the device 10 enters the austenite phase and expands into its deployed shape.
- the device 10 may be configured to be super-elastic and automatically expand upon being-unconstrained by the catheter 450 .
- the guidewire 465 continues to push the device 10 out of the catheter until the proximal end 20 of the device 10 is deployed within the aneurysm 40 , expanding into its deployed shape, e.g., the proximal end 20 flares open, as described above with the distal end 30 .
- a current is applied to the guidewire 465 , which causes the joint 455 to sever from the proximal end 20 of the catheter 10 .
- vaso-occlusive device 110 can be delivered within the aneurysm 40 in the manner described immediately above.
- FIGS. 10 ( a )-( c ) a retractable sheath method of delivering a vaso-occlusive device, and in this case vaso-occlusive device 310 , to the aneurysm 40 is illustrated.
- the catheter 550 is steered to just within the neck 70 of the aneurysm 40 .
- the vaso-occlusive device 10 is in its undeployed shape, and is placed over an inner guidewire 565 that extends through the lumen 580 of the delivery catheter 565 .
- the outer wall 555 of the catheter 565 that defines the lumen 580 functions as a sheath.
- the assembly of the vaso-occlusive device 310 and the guidewire 565 extends through the lumen 580 of the delivery catheter 450 such that the device 10 is positioned at the distal end of the catheter 550 .
- the guidewire 565 is then pushed so that the distal end of vaso-occlusive device 310 extends out of the catheter 550 , through the neck 70 , and into the aneurysm 40 .
- the distal end 330 of the device 310 is allowed to expand into a first flattened disk adjacent the inner wall near the neck 70 within the aneurysm 40 .
- the device 310 may be configured to be in its martensite phase when delivered to the aneurysm 40 and expand upon exposure to the temperature of the aneurysm 40 .
- the temperature of the device 310 rises and the device 310 enters the austenite phase and expands into its deployed shape.
- the device 310 may be configured to be super-elastic and expand upon being unconstrained by the catheter 550 .
- the guidewire 565 continues to push the device 310 out of the catheter until the proximal end 320 of the device 310 is deployed just outside of the aneurysm 40 , expanding into its deployed shape, e.g., a second flattened disk, as described above with the distal end 330 .
- the guidewire 565 is pulled out of the device 310 and the catheter 550 is pulled out of the aneurysm 40 and blood vessel 60 .
- the expanded 310 device is secured in position within the aneurysm 40 and will not be pulled out with the catheter 550 .
- other types of vaso-occlusive devices such as vaso-occlusive device 310 , can be delivered within the aneurysm 40 in the manner described immediately above.
- a vaso-occlusive device such as vaso-occlusive device 310
- finer vaso-occlusive devices 730 may be delivered into the aneurysm 40 to be retained by the device 310 , as illustrated in FIG. 10( d ). This is achieved by maintaining an axial lumen within a vaso-occlusive device to allow a catheter 740 to fit through and insert materials such as vaso-occlusive coils 730 or embolic liquids to further improve thrombogenecity within the aneurysm 700 .
- FIGS. 11 ( a )-( c ) a push method of delivering a vaso-occlusive device, and in this case vaso-occlusive device 210 , to the aneurysm 40 is illustrated.
- the catheter 650 is steered to just within the neck 70 of the aneurysm 40 .
- the vaso-occlusive device 210 is in its undeployed shape, and is placed within the lumen 680 of a delivery catheter 650 near the distal tip of the catheter 650 , which is steered to aneurysm 40 , just outside of the neck 70 .
- a guidewire 665 extending through the lumen 655 is positioned such that it is capable of pushing the device 210 out of the catheter 650 and into the aneurysm 40 , where the device 230 may expand into its deployed shape, as described above.
- the guidewire 665 is then pushed so that the distal end of vaso-occlusive device 210 extends out of the catheter 650 , through the neck 70 , and into the aneurysm 40 .
- the distal end 230 of the device 210 is allowed to expand into a flared open cup shape adjacent the inner wall near the neck 70 within the aneurysm 40 .
- the device 210 may be configured to be in its martensite phase when delivered to the aneurysm 40 and expand upon exposure to the temperature of the aneurysm 40 .
- the temperature of the device 210 rises and the device 210 enters the austenite phase and expands into its deployed shape.
- the device 210 may be configured to be super-elastic and expand upon being unconstrained by the catheter 650 .
- the guidewire 665 continues to push the device 210 out of the catheter until the proximal end 220 of the device 210 is deployed just outside of the aneurysm 40 , expanding into its deployed shape, e.g., a flattened disk, as described above with the distal end 230 .
- the catheter 650 is then pulled out of the aneurysm 40 and blood vessel 60 to separate itself from the device 210 .
- the expanded 210 device is secured in position within the aneurysm 40 and will not be pulled out with the catheter 650 .
- other types of vaso-occlusive devices such as vaso-occlusive device 210 , can be delivered within the aneurysm 40 in the manner described immediately above.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medical Informatics (AREA)
- Reproductive Health (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgical Instruments (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/121,980 US20030195553A1 (en) | 2002-04-12 | 2002-04-12 | System and method for retaining vaso-occlusive devices within an aneurysm |
EP03721607A EP1494619B1 (fr) | 2002-04-12 | 2003-04-10 | Dispositifs permettant de retenir des dispositifs pour l'occlusion vasculaire dans un anevrysme |
AU2003224913A AU2003224913A1 (en) | 2002-04-12 | 2003-04-10 | Devices for retaining vaso-occlussive devices within an aneurysm |
AT03721607T ATE439092T1 (de) | 2002-04-12 | 2003-04-10 | Vorrichtungen zum festhalten von vasookklusiven vorrichtungen in einem aneurysma |
DE60328765T DE60328765D1 (de) | 2002-04-12 | 2003-04-10 | Vorrichtungen zum festhalten von vasookklusiven vorrichtungen in einem aneurysma |
JP2003583267A JP4414767B2 (ja) | 2002-04-12 | 2003-04-10 | 動脈瘤内の脈管閉塞装置の固定装置 |
CA2481224A CA2481224C (fr) | 2002-04-12 | 2003-04-10 | Dispositifs permettant de retenir des dispositifs pour l'occlusion vasculaire dans un anevrysme |
PCT/US2003/010997 WO2003086240A1 (fr) | 2002-04-12 | 2003-04-10 | Dispositifs permettant de retenir des dispositifs pour l'occlusion vasculaire dans un anevrysme |
ES03721607T ES2331567T3 (es) | 2002-04-12 | 2003-04-10 | Dispositivos para la retencion de dispositivos vaso-oclusivos dentro de un aneurisma. |
US11/617,293 US20070106311A1 (en) | 2002-04-12 | 2006-12-28 | System and method for retaining vaso-occlusive devices within an aneurysm |
US13/091,608 US9314326B2 (en) | 2002-04-12 | 2011-04-21 | System and method for retaining vaso-occlusive devices within an aneurysm |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/121,980 US20030195553A1 (en) | 2002-04-12 | 2002-04-12 | System and method for retaining vaso-occlusive devices within an aneurysm |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/617,293 Continuation US20070106311A1 (en) | 2002-04-12 | 2006-12-28 | System and method for retaining vaso-occlusive devices within an aneurysm |
Publications (1)
Publication Number | Publication Date |
---|---|
US20030195553A1 true US20030195553A1 (en) | 2003-10-16 |
Family
ID=28790456
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/121,980 Abandoned US20030195553A1 (en) | 2002-04-12 | 2002-04-12 | System and method for retaining vaso-occlusive devices within an aneurysm |
US11/617,293 Abandoned US20070106311A1 (en) | 2002-04-12 | 2006-12-28 | System and method for retaining vaso-occlusive devices within an aneurysm |
US13/091,608 Active 2024-12-10 US9314326B2 (en) | 2002-04-12 | 2011-04-21 | System and method for retaining vaso-occlusive devices within an aneurysm |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/617,293 Abandoned US20070106311A1 (en) | 2002-04-12 | 2006-12-28 | System and method for retaining vaso-occlusive devices within an aneurysm |
US13/091,608 Active 2024-12-10 US9314326B2 (en) | 2002-04-12 | 2011-04-21 | System and method for retaining vaso-occlusive devices within an aneurysm |
Country Status (9)
Country | Link |
---|---|
US (3) | US20030195553A1 (fr) |
EP (1) | EP1494619B1 (fr) |
JP (1) | JP4414767B2 (fr) |
AT (1) | ATE439092T1 (fr) |
AU (1) | AU2003224913A1 (fr) |
CA (1) | CA2481224C (fr) |
DE (1) | DE60328765D1 (fr) |
ES (1) | ES2331567T3 (fr) |
WO (1) | WO2003086240A1 (fr) |
Cited By (109)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050049681A1 (en) * | 2003-05-19 | 2005-03-03 | Secant Medical, Llc | Tissue distention device and related methods for therapeutic intervention |
US20050283183A1 (en) * | 2004-06-21 | 2005-12-22 | Tri Tran | Expanding vaso-occlusive device |
US20060064151A1 (en) * | 2004-09-22 | 2006-03-23 | Guterman Lee R | Cranial aneurysm treatment arrangement |
US20060155323A1 (en) * | 2005-01-07 | 2006-07-13 | Porter Stephen C | Intra-aneurysm devices |
US20060247680A1 (en) * | 2004-04-08 | 2006-11-02 | Aga Medical Corporation | Flanged occlusion devices and methods |
US20070088387A1 (en) * | 2005-10-19 | 2007-04-19 | Pulsar Vascular, Inc. | Implantable aneurysm closure systems and methods |
US20070233174A1 (en) * | 2005-04-01 | 2007-10-04 | Gordon Hocking | Trapping Filter for Blood Vessel |
US20070270902A1 (en) * | 2004-09-17 | 2007-11-22 | Slazas Robert R | Thin Film Metallic Devices for Plugging Aneurysms or Vessels |
WO2007140797A1 (fr) * | 2006-06-02 | 2007-12-13 | Occlutech Gmbh | Instrument d'occlusion pour fermer un appendice auriculaire cardiaque |
EP1901665A2 (fr) * | 2005-07-11 | 2008-03-26 | USGI Medical Inc | Ensembles ancrages de tissu compressibles |
US20080200945A1 (en) * | 2004-03-19 | 2008-08-21 | Aga Medical Corporation | Device for occluding vascular defects |
US20080221600A1 (en) * | 2006-08-17 | 2008-09-11 | Dieck Martin S | Isolation devices for the treatment of aneurysms |
US20090062841A1 (en) * | 2004-03-19 | 2009-03-05 | Aga Medical Corporation | Device for occluding vascular defects |
US20110046719A1 (en) * | 2004-06-03 | 2011-02-24 | Noureddine Frid | Luminal Endoprosthesis For the Occlusion of an Aneurysm and Method of Manufacturing Such an Endoprosthesis |
US8142456B2 (en) | 2008-04-21 | 2012-03-27 | Nfocus Neuromedical, Inc. | Braid-ball embolic devices |
US20120271337A1 (en) * | 2007-04-16 | 2012-10-25 | Hans-Reiner Figulla | Occluder For Occluding an Atrial Appendage and Production Process Therefor |
WO2012163880A1 (fr) * | 2011-05-31 | 2012-12-06 | Acandis Gmbh & Co. Kg | Implant médical à disposer à l'intérieur d'un corps creux, en particulier d'un anévrisme, et procédé de fabrication d'un implant médical |
US20130012979A1 (en) * | 2004-03-19 | 2013-01-10 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US8388650B2 (en) | 2008-09-05 | 2013-03-05 | Pulsar Vascular, Inc. | Systems and methods for supporting or occluding a physiological opening or cavity |
US8425548B2 (en) | 2010-07-01 | 2013-04-23 | Aneaclose LLC | Occluding member expansion and then stent expansion for aneurysm treatment |
AU2010249161B2 (en) * | 2004-01-22 | 2013-05-16 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8551132B2 (en) | 2005-10-19 | 2013-10-08 | Pulsar Vascular, Inc. | Methods and systems for endovascularly clipping and repairing lumen and tissue defects |
US8636760B2 (en) | 2009-04-20 | 2014-01-28 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US8747453B2 (en) | 2008-02-18 | 2014-06-10 | Aga Medical Corporation | Stent/stent graft for reinforcement of vascular abnormalities and associated method |
US8777974B2 (en) * | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
WO2014128313A1 (fr) * | 2013-02-21 | 2014-08-28 | Castaño Duque Carlos | Dispositif de support et de placement d'éléments occlusifs |
WO2014137467A1 (fr) * | 2013-03-05 | 2014-09-12 | Aga Medical Corporation | Dispositif médical pour traiter un site cible |
US20140350588A1 (en) * | 2011-11-09 | 2014-11-27 | Easynotes Ltd. | Obstruction device |
US8906057B2 (en) | 2010-01-04 | 2014-12-09 | Aneuclose Llc | Aneurysm embolization by rotational accumulation of mass |
US8926681B2 (en) | 2010-01-28 | 2015-01-06 | Covidien Lp | Vascular remodeling device |
US8974487B2 (en) | 2008-05-01 | 2015-03-10 | Aneuclose Llc | Aneurysm occlusion device |
JP2015083139A (ja) * | 2005-10-19 | 2015-04-30 | パルサー バスキュラー インコーポレイテッド | 脈管内をクリッピングし、腔内および組織欠損を修復するための方法およびシステム |
US9023094B2 (en) | 2007-06-25 | 2015-05-05 | Microvention, Inc. | Self-expanding prosthesis |
US9060886B2 (en) | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
US9089332B2 (en) | 2011-03-25 | 2015-07-28 | Covidien Lp | Vascular remodeling device |
US9095343B2 (en) | 2005-05-25 | 2015-08-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9095342B2 (en) | 2009-11-09 | 2015-08-04 | Covidien Lp | Braid ball embolic device features |
US9119625B2 (en) | 2011-10-05 | 2015-09-01 | Pulsar Vascular, Inc. | Devices, systems and methods for enclosing an anatomical opening |
US9138232B2 (en) | 2011-05-24 | 2015-09-22 | Aneuclose Llc | Aneurysm occlusion by rotational dispensation of mass |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
WO2015166013A1 (fr) | 2014-04-30 | 2015-11-05 | Cerus Endovascular Limited | Dispositif d'occlusion |
US9179918B2 (en) | 2008-07-22 | 2015-11-10 | Covidien Lp | Vascular remodeling device |
US9186267B2 (en) | 2012-10-31 | 2015-11-17 | Covidien Lp | Wing bifurcation reconstruction device |
CN105105812A (zh) * | 2015-09-18 | 2015-12-02 | 王奎重 | 一种颅内动脉瘤介入栓塞治疗装置 |
US9204983B2 (en) | 2005-05-25 | 2015-12-08 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9259229B2 (en) | 2012-05-10 | 2016-02-16 | Pulsar Vascular, Inc. | Systems and methods for enclosing an anatomical opening, including coil-tipped aneurysm devices |
US9277924B2 (en) | 2009-09-04 | 2016-03-08 | Pulsar Vascular, Inc. | Systems and methods for enclosing an anatomical opening |
US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
US9351859B2 (en) | 2010-12-06 | 2016-05-31 | Covidien Lp | Vascular remodeling device |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US9393022B2 (en) | 2011-02-11 | 2016-07-19 | Covidien Lp | Two-stage deployment aneurysm embolization devices |
US20160213459A1 (en) * | 2013-03-15 | 2016-07-28 | Insera Therapeutics, Inc. | Vascular treatment devices and methods |
WO2016161344A1 (fr) * | 2015-04-01 | 2016-10-06 | Boston Scientific Scimed, Inc. | Systèmes et procédés d'administration d'emboliques en gel |
US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
US9468442B2 (en) | 2010-01-28 | 2016-10-18 | Covidien Lp | Vascular remodeling device |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
US20170252045A1 (en) * | 2013-03-13 | 2017-09-07 | Lawrence Livermore National Security, Llc | Shape-memory polymer foam device for treating aneurysms |
WO2017153603A1 (fr) | 2016-03-11 | 2017-09-14 | Cerus Endovascular Limited | Dispositif d'occlusion |
WO2017201316A1 (fr) * | 2016-05-18 | 2017-11-23 | Microvention, Inc. | Confinement embolique |
US10004510B2 (en) | 2011-06-03 | 2018-06-26 | Pulsar Vascular, Inc. | Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices |
US10028745B2 (en) | 2011-03-30 | 2018-07-24 | Noha, Llc | Advanced endovascular clip and method of using same |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US20180242979A1 (en) * | 2017-02-23 | 2018-08-30 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US20180333158A1 (en) * | 2015-02-25 | 2018-11-22 | Galaxy Therapeutics, Llc | System for and method of treating aneurysms |
US10327781B2 (en) | 2012-11-13 | 2019-06-25 | Covidien Lp | Occlusive devices |
US20190223876A1 (en) * | 2018-01-19 | 2019-07-25 | Galaxy Therapeutics, Llc | System for and method of treating aneurysms |
US10390926B2 (en) | 2013-07-29 | 2019-08-27 | Insera Therapeutics, Inc. | Aspiration devices and methods |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US10555738B2 (en) | 2016-05-18 | 2020-02-11 | Microvention, Inc. | Embolic containment |
EP2228020B2 (fr) † | 2004-03-19 | 2020-03-18 | AGA Medical Corporation | Structures tressées multicouches pour boucher des defects vasculaires |
US20200100795A1 (en) * | 2008-05-01 | 2020-04-02 | Aneuclose Llc | "Bowl-of-Spaghetti" Type Intrasacular Aneurysm Occlusion Device |
CN111031938A (zh) * | 2017-08-22 | 2020-04-17 | 柯惠有限合伙公司 | 用于治疗血管缺损的装置、***和方法 |
US10624647B2 (en) | 2011-06-03 | 2020-04-21 | Pulsar Vascular, Inc. | Aneurysm devices with additional anchoring mechanisms and associated systems and methods |
US10653425B1 (en) | 2019-05-21 | 2020-05-19 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US10736758B2 (en) | 2013-03-15 | 2020-08-11 | Covidien | Occlusive device |
US10856880B1 (en) | 2019-05-25 | 2020-12-08 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US10905430B2 (en) | 2018-01-24 | 2021-02-02 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10939915B2 (en) | 2018-05-31 | 2021-03-09 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11058430B2 (en) * | 2018-05-25 | 2021-07-13 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
CN113180882A (zh) * | 2016-06-21 | 2021-07-30 | 内流医疗有限公司 | 用于治疗血管畸形部的装置及试剂盒 |
US11076860B2 (en) | 2014-03-31 | 2021-08-03 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US11076861B2 (en) * | 2018-10-12 | 2021-08-03 | DePuy Synthes Products, Inc. | Folded aneurysm treatment device and delivery method |
WO2021130064A3 (fr) * | 2019-12-23 | 2021-08-19 | Phenox Gmbh | Implant pour traiter des anévrismes |
US11123077B2 (en) | 2018-09-25 | 2021-09-21 | DePuy Synthes Products, Inc. | Intrasaccular device positioning and deployment system |
US11134953B2 (en) | 2019-02-06 | 2021-10-05 | DePuy Synthes Products, Inc. | Adhesive cover occluding device for aneurysm treatment |
US11154302B2 (en) | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US11272939B2 (en) * | 2018-12-18 | 2022-03-15 | DePuy Synthes Products, Inc. | Intrasaccular flow diverter for treating cerebral aneurysms |
US11278292B2 (en) | 2019-05-21 | 2022-03-22 | DePuy Synthes Products, Inc. | Inverting braided aneurysm treatment system and method |
US11284903B2 (en) | 2011-03-30 | 2022-03-29 | Hesham Morsi | Advanced endovascular clip and method of using same |
CN114391910A (zh) * | 2014-12-31 | 2022-04-26 | 先健科技(深圳)有限公司 | 左心耳封堵器 |
US11337706B2 (en) | 2019-03-27 | 2022-05-24 | DePuy Synthes Products, Inc. | Aneurysm treatment device |
US11406392B2 (en) | 2018-12-12 | 2022-08-09 | DePuy Synthes Products, Inc. | Aneurysm occluding device for use with coagulating agents |
US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
US11413046B2 (en) | 2019-05-21 | 2022-08-16 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11457926B2 (en) | 2019-12-18 | 2022-10-04 | DePuy Synthes Products, Inc. | Implant having an intrasaccular section and intravascular section |
US11471162B2 (en) | 2015-12-07 | 2022-10-18 | Cerus Endovascular Limited | Occlusion device |
US11497504B2 (en) | 2019-05-21 | 2022-11-15 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable implanted braid |
US11583288B2 (en) | 2018-08-08 | 2023-02-21 | DePuy Synthes Products, Inc. | Delivery of embolic braid |
US11596412B2 (en) | 2018-05-25 | 2023-03-07 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11602350B2 (en) | 2019-12-05 | 2023-03-14 | DePuy Synthes Products, Inc. | Intrasaccular inverting braid with highly flexible fill material |
US11607226B2 (en) | 2019-05-21 | 2023-03-21 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device with corrugations |
US11633818B2 (en) | 2019-11-04 | 2023-04-25 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
US11672542B2 (en) | 2019-05-21 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable ball segment |
CN116687496A (zh) * | 2023-08-04 | 2023-09-05 | 北京久事神康医疗科技有限公司 | 一种带网盘的栓塞装置 |
US11812971B2 (en) | 2017-08-21 | 2023-11-14 | Cerus Endovascular Limited | Occlusion device |
US11986189B2 (en) | 2021-01-27 | 2024-05-21 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US12042151B2 (en) * | 2020-09-15 | 2024-07-23 | Stryker Corporation and Stryker European Operations Holdings LLC | Intra-aneurysm devices |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8845676B2 (en) | 2004-09-22 | 2014-09-30 | Micro Therapeutics | Micro-spiral implantation device |
EP1793744B1 (fr) | 2004-09-22 | 2008-12-17 | Dendron GmbH | Implant medical |
WO2007006139A1 (fr) * | 2005-07-12 | 2007-01-18 | Smart Biotech Inc. | Dispositif d’occlusion d’anévrisme |
US8864790B2 (en) | 2006-04-17 | 2014-10-21 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8372114B2 (en) * | 2006-11-13 | 2013-02-12 | Electroformed Stents, Inc. | Over-the-wire exclusion device and system for delivery |
KR20100015520A (ko) | 2007-03-13 | 2010-02-12 | 마이크로 테라퓨틱스 인코포레이티드 | 코일과 펴짐방지 부재를 포함하는 임플란트 |
US20090227938A1 (en) * | 2008-03-05 | 2009-09-10 | Insitu Therapeutics, Inc. | Wound Closure Devices, Methods of Use, and Kits |
US11484322B2 (en) | 2018-01-03 | 2022-11-01 | Aneuclose Llc | Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac |
US11464518B2 (en) | 2008-05-01 | 2022-10-11 | Aneuclose Llc | Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms |
US11471163B2 (en) | 2008-05-01 | 2022-10-18 | Aneuclose Llc | Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies |
US20100131002A1 (en) * | 2008-11-24 | 2010-05-27 | Connor Robert A | Stent with a net layer to embolize and aneurysm |
US20110034941A1 (en) * | 2009-08-10 | 2011-02-10 | Joseph Iraci | Surgical Instrument for Hernia Repair and Method |
WO2011098633A1 (fr) * | 2010-02-12 | 2011-08-18 | Vasuclip, S.L. | Dispositif pour l'occlusion d'un anévrisme et méthode de traitement |
US9579104B2 (en) | 2011-11-30 | 2017-02-28 | Covidien Lp | Positioning and detaching implants |
US9011480B2 (en) | 2012-01-20 | 2015-04-21 | Covidien Lp | Aneurysm treatment coils |
US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
WO2013159065A1 (fr) * | 2012-04-20 | 2013-10-24 | Paul Lubock | Dispositifs d'occlusion expansibles et procédés d'utilisation |
US8715314B1 (en) | 2013-03-15 | 2014-05-06 | Insera Therapeutics, Inc. | Vascular treatment measurement methods |
US8679150B1 (en) | 2013-03-15 | 2014-03-25 | Insera Therapeutics, Inc. | Shape-set textile structure based mechanical thrombectomy methods |
US8690907B1 (en) | 2013-03-15 | 2014-04-08 | Insera Therapeutics, Inc. | Vascular treatment methods |
US20150018860A1 (en) | 2013-07-12 | 2015-01-15 | Inceptus Medical, Llc | Methods and apparatus for treating small vessel thromboembolisms |
US9629635B2 (en) * | 2014-04-14 | 2017-04-25 | Sequent Medical, Inc. | Devices for therapeutic vascular procedures |
US9713475B2 (en) | 2014-04-18 | 2017-07-25 | Covidien Lp | Embolic medical devices |
US9918718B2 (en) | 2014-08-08 | 2018-03-20 | DePuy Synthes Products, Inc. | Embolic coil delivery system with retractable mechanical release mechanism |
US10925611B2 (en) | 2015-01-20 | 2021-02-23 | Neurogami Medical, Inc. | Packaging for surgical implant |
EP3247285B1 (fr) | 2015-01-20 | 2021-08-11 | Neurogami Medical, Inc. | Microgreffe pour le traitement d'anévrismes intracrâniens |
US10857012B2 (en) | 2015-01-20 | 2020-12-08 | Neurogami Medical, Inc. | Vascular implant |
US10736730B2 (en) | 2015-01-20 | 2020-08-11 | Neurogami Medical, Inc. | Vascular implant |
US11484319B2 (en) | 2015-01-20 | 2022-11-01 | Neurogami Medical, Inc. | Delivery system for micrograft for treating intracranial aneurysms |
DE102015104785A1 (de) * | 2015-03-27 | 2016-09-29 | Pfm Medical Ag | Vorrichtung zum Verschließen eines Herzohrs |
WO2017106567A1 (fr) * | 2015-12-15 | 2017-06-22 | Nsvascular, Inc. | Déviateurs de flux intrasacculaire à film fin et procédés associés |
EP3413808B1 (fr) | 2016-02-10 | 2023-07-26 | Microvention, Inc. | Dispositifs pour occlusion vasculaire |
US10420563B2 (en) | 2016-07-08 | 2019-09-24 | Neurogami Medical, Inc. | Delivery system insertable through body lumen |
US20180049859A1 (en) * | 2016-08-16 | 2018-02-22 | Spartan Micro, Inc. | Intravascular flow diversion devices |
CN113215721B (zh) | 2016-10-14 | 2023-02-17 | 因赛普特斯医学有限责任公司 | 编织机器和使用方法 |
US11202699B2 (en) * | 2016-10-21 | 2021-12-21 | Javelin Medical Ltd. | Systems, methods and devices for embolic protection |
US10376267B2 (en) | 2017-02-24 | 2019-08-13 | Inceptus Medical, Llc | Vascular occlusion devices and methods |
US11812968B2 (en) * | 2017-05-10 | 2023-11-14 | Lifetech Scientific (Shenzhen) Co. Ltd. | Left atrial appendage occluder |
WO2019075444A1 (fr) | 2017-10-14 | 2019-04-18 | Inceptus Medical. Llc | Machine à tresser et ses procédés d'utilisation |
US10806462B2 (en) | 2017-12-21 | 2020-10-20 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with split tube and cylindrical coupling |
US10751065B2 (en) | 2017-12-22 | 2020-08-25 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10716574B2 (en) | 2017-12-22 | 2020-07-21 | DePuy Synthes Products, Inc. | Aneurysm device and delivery method |
US11147562B2 (en) | 2018-12-12 | 2021-10-19 | DePuy Synthes Products, Inc. | Systems and methods for embolic implant detachment |
US11253265B2 (en) | 2019-06-18 | 2022-02-22 | DePuy Synthes Products, Inc. | Pull wire detachment for intravascular devices |
US11207494B2 (en) | 2019-07-03 | 2021-12-28 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant distal portion |
US11426174B2 (en) | 2019-10-03 | 2022-08-30 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant mechanical release |
US11439403B2 (en) | 2019-09-17 | 2022-09-13 | DePuy Synthes Products, Inc. | Embolic coil proximal connecting element and stretch resistant fiber |
US11376013B2 (en) | 2019-11-18 | 2022-07-05 | DePuy Synthes Products, Inc. | Implant delivery system with braid cup formation |
US11457922B2 (en) | 2020-01-22 | 2022-10-04 | DePuy Synthes Products, Inc. | Medical device delivery member with flexible stretch resistant distal portion |
US11432822B2 (en) | 2020-02-14 | 2022-09-06 | DePuy Synthes Products, Inc. | Intravascular implant deployment system |
US11951026B2 (en) | 2020-06-30 | 2024-04-09 | DePuy Synthes Products, Inc. | Implantable medical device detachment system with flexible braid section |
JP7427202B2 (ja) * | 2021-05-28 | 2024-02-05 | 有限会社ウサミナノテクノロジー | 動脈瘤頚部塞栓部材および動脈瘤頚部塞栓部材の製造方法 |
US11998213B2 (en) | 2021-07-14 | 2024-06-04 | DePuy Synthes Products, Inc. | Implant delivery with modified detachment feature and pull wire engagement |
US11844490B2 (en) | 2021-12-30 | 2023-12-19 | DePuy Synthes Products, Inc. | Suture linkage for inhibiting premature embolic implant deployment |
US11937824B2 (en) | 2021-12-30 | 2024-03-26 | DePuy Synthes Products, Inc. | Implant detachment systems with a modified pull wire |
US12011171B2 (en) | 2022-01-06 | 2024-06-18 | DePuy Synthes Products, Inc. | Systems and methods for inhibiting premature embolic implant deployment |
US11937825B2 (en) | 2022-03-02 | 2024-03-26 | DePuy Synthes Products, Inc. | Hook wire for preventing premature embolic implant detachment |
US11937826B2 (en) | 2022-03-14 | 2024-03-26 | DePuy Synthes Products, Inc. | Proximal link wire for preventing premature implant detachment |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4739768A (en) * | 1986-06-02 | 1988-04-26 | Target Therapeutics | Catheter for guide-wire tracking |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5122136A (en) * | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5250071A (en) * | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
US5261916A (en) * | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
US5354295A (en) * | 1990-03-13 | 1994-10-11 | Target Therapeutics, Inc. | In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5928260A (en) * | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US5944750A (en) * | 1997-06-30 | 1999-08-31 | Eva Corporation | Method and apparatus for the surgical repair of aneurysms |
US6063070A (en) * | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
US6077281A (en) * | 1992-01-21 | 2000-06-20 | Regents Of The University Of Minnesota | Septal defect closure device |
US6080182A (en) * | 1996-12-20 | 2000-06-27 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US6086577A (en) * | 1997-08-13 | 2000-07-11 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (III) |
US6168622B1 (en) * | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US6346117B1 (en) * | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6375668B1 (en) * | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
Family Cites Families (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US634617A (en) * | 1898-09-06 | 1899-10-10 | Charles H Hansen | Brush. |
US4830003A (en) * | 1988-06-17 | 1989-05-16 | Wolff Rodney G | Compressive stent and delivery system |
US4991602A (en) * | 1989-06-27 | 1991-02-12 | Flexmedics Corporation | Flexible guide wire with safety tip |
US5527338A (en) * | 1992-09-02 | 1996-06-18 | Board Of Regents, The University Of Texas System | Intravascular device |
ES2340142T3 (es) * | 1994-07-08 | 2010-05-31 | Ev3 Inc. | Sistema para llevar a cabo un procedimiento intravascular. |
US5725552A (en) | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US6123715A (en) | 1994-07-08 | 2000-09-26 | Amplatz; Curtis | Method of forming medical devices; intravascular occlusion devices |
US8790363B2 (en) | 1995-04-20 | 2014-07-29 | DePuy Synthes Products, LLC | Three dimensional, low friction vasoocclusive coil, and method of manufacture |
US5944730A (en) * | 1997-05-19 | 1999-08-31 | Cardio Medical Solutions, Inc. | Device and method for assisting end-to-side anastomosis |
US5951599A (en) | 1997-07-09 | 1999-09-14 | Scimed Life Systems, Inc. | Occlusion system for endovascular treatment of an aneurysm |
GB9715241D0 (en) | 1997-07-18 | 1997-09-24 | Jeffree Martin A | Device for treating aneurysms |
ATE339919T1 (de) | 1997-08-04 | 2006-10-15 | Boston Scient Ltd | Okklussionssystem zum ausbessern eines aneurysmas |
US6511468B1 (en) | 1997-10-17 | 2003-01-28 | Micro Therapeutics, Inc. | Device and method for controlling injection of liquid embolic composition |
US6159165A (en) | 1997-12-05 | 2000-12-12 | Micrus Corporation | Three dimensional spherical micro-coils manufactured from radiopaque nickel-titanium microstrand |
US5944738A (en) * | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
ES2343228T3 (es) | 1998-02-10 | 2010-07-26 | Ethicon Endo-Surgery, Inc. | Aparato de oclusion, de anclaje, de tensionado o de direccion por flujo. |
US6168615B1 (en) | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
US6093199A (en) | 1998-08-05 | 2000-07-25 | Endovascular Technologies, Inc. | Intra-luminal device for treatment of body cavities and lumens and method of use |
DE69936869T2 (de) | 1998-09-04 | 2008-05-15 | Boston Scientific Ltd., St. Michael | Ablösbares system zum verschliessen eines aneurysmashalses |
US7044134B2 (en) * | 1999-11-08 | 2006-05-16 | Ev3 Sunnyvale, Inc | Method of implanting a device in the left atrial appendage |
US6613074B1 (en) | 1999-03-10 | 2003-09-02 | Cordis Corporation | Endovascular aneurysm embolization device |
US6238403B1 (en) | 1999-10-04 | 2001-05-29 | Microvention, Inc. | Filamentous embolic device with expansible elements |
US6551303B1 (en) * | 1999-10-27 | 2003-04-22 | Atritech, Inc. | Barrier device for ostium of left atrial appendage |
US6391037B1 (en) | 2000-03-02 | 2002-05-21 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
US6454780B1 (en) | 2001-06-21 | 2002-09-24 | Scimed Life Systems, Inc. | Aneurysm neck obstruction device |
US6811560B2 (en) | 2001-09-20 | 2004-11-02 | Cordis Neurovascular, Inc. | Stent aneurysm embolization method and device |
US6638257B2 (en) | 2002-03-01 | 2003-10-28 | Aga Medical Corporation | Intravascular flow restrictor |
US8313505B2 (en) | 2004-03-19 | 2012-11-20 | Aga Medical Corporation | Device for occluding vascular defects |
US8777974B2 (en) | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US8398670B2 (en) | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
WO2005099365A2 (fr) | 2004-04-08 | 2005-10-27 | Aga Medical Corporation | Dispositifs et procedes d'occlusion a brides |
WO2006034153A2 (fr) * | 2004-09-17 | 2006-03-30 | Cordis Neurovascular, Inc. | Dispositifs metalliques a film mince pour l'obturation d'anevrismes ou de vaisseaux |
JP2008515467A (ja) | 2004-09-17 | 2008-05-15 | コーディス・ニューロバスキュラー・インコーポレイテッド | 塞栓性メッシュリボンを備えた血管閉塞器具 |
US8864790B2 (en) | 2006-04-17 | 2014-10-21 | Covidien Lp | System and method for mechanically positioning intravascular implants |
US8034061B2 (en) | 2007-07-12 | 2011-10-11 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US8361138B2 (en) | 2007-07-25 | 2013-01-29 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
US20090112251A1 (en) | 2007-07-25 | 2009-04-30 | Aga Medical Corporation | Braided occlusion device having repeating expanded volume segments separated by articulation segments |
EP2190380A1 (fr) | 2007-09-11 | 2010-06-02 | NFocus Neuromedical, Inc. | Dispositif de coiffe d'anévrisme pour l'implantation et la retenue d'agents emboliques |
US9743918B2 (en) | 2008-01-18 | 2017-08-29 | St. Jude Medical, Cardiology Division, Inc. | Percutaneous catheter directed intravascular occlusion device |
SG189809A1 (en) | 2008-04-21 | 2013-05-31 | Nfocus Neuromedical Inc | Braid-ball embolic devices and delivery systems |
US9232992B2 (en) | 2008-07-24 | 2016-01-12 | Aga Medical Corporation | Multi-layered medical device for treating a target site and associated method |
US9427304B2 (en) | 2008-10-27 | 2016-08-30 | St. Jude Medical, Cardiology Division, Inc. | Multi-layer device with gap for treating a target site and associated method |
US8940015B2 (en) | 2008-11-11 | 2015-01-27 | Aga Medical Corporation | Asymmetrical medical devices for treating a target site and associated method |
US8906057B2 (en) * | 2010-01-04 | 2014-12-09 | Aneuclose Llc | Aneurysm embolization by rotational accumulation of mass |
US8821529B2 (en) | 2011-03-25 | 2014-09-02 | Aga Medical Corporation | Device and method for occluding a septal defect |
US8511214B2 (en) | 2011-04-21 | 2013-08-20 | Aga Medical Corporation | Tubular structure and method for making the same |
US8764787B2 (en) * | 2011-06-17 | 2014-07-01 | Aga Medical Corporation | Occlusion device and associated deployment method |
US8758389B2 (en) | 2011-11-18 | 2014-06-24 | Aga Medical Corporation | Devices and methods for occluding abnormal openings in a patient's vasculature |
US9113890B2 (en) | 2012-02-06 | 2015-08-25 | Aga Medical Corporation | Devices and methods for occluding vascular abnormalities |
US9687245B2 (en) | 2012-03-23 | 2017-06-27 | Covidien Lp | Occlusive devices and methods of use |
KR20150084959A (ko) | 2012-11-13 | 2015-07-22 | 코비디엔 엘피 | 폐색 장치 |
US10973523B2 (en) | 2013-03-08 | 2021-04-13 | Aga Medical Corporation | Medical device for treating a target site |
-
2002
- 2002-04-12 US US10/121,980 patent/US20030195553A1/en not_active Abandoned
-
2003
- 2003-04-10 AT AT03721607T patent/ATE439092T1/de not_active IP Right Cessation
- 2003-04-10 DE DE60328765T patent/DE60328765D1/de not_active Expired - Lifetime
- 2003-04-10 ES ES03721607T patent/ES2331567T3/es not_active Expired - Lifetime
- 2003-04-10 AU AU2003224913A patent/AU2003224913A1/en not_active Abandoned
- 2003-04-10 JP JP2003583267A patent/JP4414767B2/ja not_active Expired - Lifetime
- 2003-04-10 CA CA2481224A patent/CA2481224C/fr not_active Expired - Fee Related
- 2003-04-10 WO PCT/US2003/010997 patent/WO2003086240A1/fr active Application Filing
- 2003-04-10 EP EP03721607A patent/EP1494619B1/fr not_active Expired - Lifetime
-
2006
- 2006-12-28 US US11/617,293 patent/US20070106311A1/en not_active Abandoned
-
2011
- 2011-04-21 US US13/091,608 patent/US9314326B2/en active Active
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4739768B1 (en) * | 1986-06-02 | 1994-11-15 | Target Therapeutics Inc | Catheter for guide-wire tracking |
US4739768B2 (en) * | 1986-06-02 | 1995-10-24 | Target Therapeutics Inc | Catheter for guide-wire tracking |
US4739768A (en) * | 1986-06-02 | 1988-04-26 | Target Therapeutics | Catheter for guide-wire tracking |
US4994069A (en) * | 1988-11-02 | 1991-02-19 | Target Therapeutics | Vaso-occlusion coil and method |
US5122136A (en) * | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5354295A (en) * | 1990-03-13 | 1994-10-11 | Target Therapeutics, Inc. | In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5261916A (en) * | 1991-12-12 | 1993-11-16 | Target Therapeutics | Detachable pusher-vasoocclusive coil assembly with interlocking ball and keyway coupling |
US6077281A (en) * | 1992-01-21 | 2000-06-20 | Regents Of The University Of Minnesota | Septal defect closure device |
US5250071A (en) * | 1992-09-22 | 1993-10-05 | Target Therapeutics, Inc. | Detachable embolic coil assembly using interlocking clasps and method of use |
US6168622B1 (en) * | 1996-01-24 | 2001-01-02 | Microvena Corporation | Method and apparatus for occluding aneurysms |
US6080182A (en) * | 1996-12-20 | 2000-06-27 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US5944750A (en) * | 1997-06-30 | 1999-08-31 | Eva Corporation | Method and apparatus for the surgical repair of aneurysms |
US5928260A (en) * | 1997-07-10 | 1999-07-27 | Scimed Life Systems, Inc. | Removable occlusion system for aneurysm neck |
US6063070A (en) * | 1997-08-05 | 2000-05-16 | Target Therapeutics, Inc. | Detachable aneurysm neck bridge (II) |
US6086577A (en) * | 1997-08-13 | 2000-07-11 | Scimed Life Systems, Inc. | Detachable aneurysm neck bridge (III) |
US6375668B1 (en) * | 1999-06-02 | 2002-04-23 | Hanson S. Gifford | Devices and methods for treating vascular malformations |
US6346117B1 (en) * | 2000-03-02 | 2002-02-12 | Prodesco, Inc. | Bag for use in the intravascular treatment of saccular aneurysms |
Cited By (229)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7122043B2 (en) | 2003-05-19 | 2006-10-17 | Stout Medical Group, L.P. | Tissue distention device and related methods for therapeutic intervention |
US7648532B2 (en) | 2003-05-19 | 2010-01-19 | Septrx, Inc. | Tissue distention device and related methods for therapeutic intervention |
US8758395B2 (en) | 2003-05-19 | 2014-06-24 | Septrx, Inc. | Embolic filtering method and apparatus |
US20050049681A1 (en) * | 2003-05-19 | 2005-03-03 | Secant Medical, Llc | Tissue distention device and related methods for therapeutic intervention |
US20060178694A1 (en) * | 2003-05-19 | 2006-08-10 | Secant Medical, Llc | Tissue distention device and related methods for therapeutic intervention |
AU2010249161B2 (en) * | 2004-01-22 | 2013-05-16 | Microvention, Inc. | Aneurysm treatment device and method of use |
US11134933B2 (en) | 2004-03-19 | 2021-10-05 | St. Jude Medical, Cardiology Division, Inc. | Multi-layer braided structures for occluding vascular defects |
US20080200945A1 (en) * | 2004-03-19 | 2008-08-21 | Aga Medical Corporation | Device for occluding vascular defects |
US9039724B2 (en) * | 2004-03-19 | 2015-05-26 | Aga Medical Corporation | Device for occluding vascular defects |
US20150133994A1 (en) * | 2004-03-19 | 2015-05-14 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US8313505B2 (en) | 2004-03-19 | 2012-11-20 | Aga Medical Corporation | Device for occluding vascular defects |
EP2228020B2 (fr) † | 2004-03-19 | 2020-03-18 | AGA Medical Corporation | Structures tressées multicouches pour boucher des defects vasculaires |
US8777974B2 (en) * | 2004-03-19 | 2014-07-15 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects |
US10624619B2 (en) | 2004-03-19 | 2020-04-21 | St. Jude Medical, Cardiology Division, Inc. | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US9877710B2 (en) * | 2004-03-19 | 2018-01-30 | St. Jude Medical, Cardiology Division, Inc. | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US20090062841A1 (en) * | 2004-03-19 | 2009-03-05 | Aga Medical Corporation | Device for occluding vascular defects |
US9445798B2 (en) | 2004-03-19 | 2016-09-20 | St. Jude Medical, Cardiology Division, Inc. | Multi-layer braided structures for occluding vascular defects |
US9445799B2 (en) | 2004-03-19 | 2016-09-20 | St. Jude Medical, Cardiology Division, Inc. | Multi-layer braided structures for occluding vascular defects |
US8398670B2 (en) | 2004-03-19 | 2013-03-19 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
US20130012979A1 (en) * | 2004-03-19 | 2013-01-10 | Aga Medical Corporation | Multi-layer braided structures for occluding vascular defects and for occluding fluid flow through portions of the vasculature of the body |
EP2856949B1 (fr) | 2004-04-08 | 2015-10-07 | Aga Medical Corporation | Dispositifs d'occlusion à bride |
US9743932B2 (en) * | 2004-04-08 | 2017-08-29 | St. Jude Medical, Cardiology Division, Inc. | Flanged occlusion devices and methods |
US11045202B2 (en) * | 2004-04-08 | 2021-06-29 | St. Jude Medical, Cardiology Division, Inc. | Flanged occlusion devices and methods |
US10231737B2 (en) | 2004-04-08 | 2019-03-19 | St. Jude Medical, Cardiology Division, Inc. | Flanged occlusion devices and methods |
EP2856949B2 (fr) † | 2004-04-08 | 2019-09-11 | Aga Medical Corporation | Dispositifs d'occlusion à bride |
US20060247680A1 (en) * | 2004-04-08 | 2006-11-02 | Aga Medical Corporation | Flanged occlusion devices and methods |
US11839379B2 (en) * | 2004-04-08 | 2023-12-12 | St. Jude Medical, Cardiology Division, Inc. | Flanged occlusion devices and methods |
US20210275183A1 (en) * | 2004-04-08 | 2021-09-09 | St. Jude Medical, Cardiology Division, Inc. | Flanged occlusion devices and methods |
US8715338B2 (en) * | 2004-06-03 | 2014-05-06 | Noureddine Frid | Luminal endoprosthesis for the occlusion of an aneurysm and method of manufacturing such an endoprosthesis |
US20110046719A1 (en) * | 2004-06-03 | 2011-02-24 | Noureddine Frid | Luminal Endoprosthesis For the Occlusion of an Aneurysm and Method of Manufacturing Such an Endoprosthesis |
US7749242B2 (en) * | 2004-06-21 | 2010-07-06 | Boston Scientific Scimed, Inc. | Expanding vaso-occlusive device |
US8486101B2 (en) | 2004-06-21 | 2013-07-16 | Stryker Corporation | Expanding vaso-occlusive device |
US20100228278A1 (en) * | 2004-06-21 | 2010-09-09 | Boston Scientific Scimed, Inc. | Expanding vaso-occlusive device |
US20050283183A1 (en) * | 2004-06-21 | 2005-12-22 | Tri Tran | Expanding vaso-occlusive device |
US20070270902A1 (en) * | 2004-09-17 | 2007-11-22 | Slazas Robert R | Thin Film Metallic Devices for Plugging Aneurysms or Vessels |
WO2006052322A2 (fr) * | 2004-09-22 | 2006-05-18 | Guterman Lee R | Systeme de traitement d'anevrisme cranien |
WO2006052322A3 (fr) * | 2004-09-22 | 2009-04-09 | Lee R Guterman | Systeme de traitement d'anevrisme cranien |
US20060064151A1 (en) * | 2004-09-22 | 2006-03-23 | Guterman Lee R | Cranial aneurysm treatment arrangement |
US12016568B2 (en) * | 2005-01-07 | 2024-06-25 | Stryker Corporation | Intra-aneurysm devices |
US20130325053A1 (en) * | 2005-01-07 | 2013-12-05 | Stryker Nv Operations Limited | Intra-aneurysm devices |
US10265075B2 (en) * | 2005-01-07 | 2019-04-23 | Stryker Corporation | Intra-aneurysm devices |
US20230015848A1 (en) * | 2005-01-07 | 2023-01-19 | Stryker Corporation | Intra-Aneurysm Devices |
US20060155323A1 (en) * | 2005-01-07 | 2006-07-13 | Porter Stephen C | Intra-aneurysm devices |
US20070233174A1 (en) * | 2005-04-01 | 2007-10-04 | Gordon Hocking | Trapping Filter for Blood Vessel |
US9381104B2 (en) | 2005-05-25 | 2016-07-05 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9204983B2 (en) | 2005-05-25 | 2015-12-08 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US10322018B2 (en) | 2005-05-25 | 2019-06-18 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US10064747B2 (en) | 2005-05-25 | 2018-09-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9198666B2 (en) | 2005-05-25 | 2015-12-01 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US9095343B2 (en) | 2005-05-25 | 2015-08-04 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
EP1901665A4 (fr) * | 2005-07-11 | 2014-01-08 | Usgi Medical Inc | Ensembles ancrages de tissu compressibles |
EP1901665A2 (fr) * | 2005-07-11 | 2008-03-26 | USGI Medical Inc | Ensembles ancrages de tissu compressibles |
US20070088387A1 (en) * | 2005-10-19 | 2007-04-19 | Pulsar Vascular, Inc. | Implantable aneurysm closure systems and methods |
JP2015083139A (ja) * | 2005-10-19 | 2015-04-30 | パルサー バスキュラー インコーポレイテッド | 脈管内をクリッピングし、腔内および組織欠損を修復するための方法およびシステム |
US8545530B2 (en) * | 2005-10-19 | 2013-10-01 | Pulsar Vascular, Inc. | Implantable aneurysm closure systems and methods |
US8551132B2 (en) | 2005-10-19 | 2013-10-08 | Pulsar Vascular, Inc. | Methods and systems for endovascularly clipping and repairing lumen and tissue defects |
US10499927B2 (en) | 2005-10-19 | 2019-12-10 | Pulsar Vascular, Inc. | Methods and systems for endovascularly clipping and repairing lumen and tissue defects |
US9510835B2 (en) | 2005-10-19 | 2016-12-06 | Pulsar Vascular, Inc. | Methods and systems for endovascularly clipping and repairing lumen and tissue defects |
WO2007140797A1 (fr) * | 2006-06-02 | 2007-12-13 | Occlutech Gmbh | Instrument d'occlusion pour fermer un appendice auriculaire cardiaque |
US20080221600A1 (en) * | 2006-08-17 | 2008-09-11 | Dieck Martin S | Isolation devices for the treatment of aneurysms |
US20120271337A1 (en) * | 2007-04-16 | 2012-10-25 | Hans-Reiner Figulla | Occluder For Occluding an Atrial Appendage and Production Process Therefor |
US9161758B2 (en) * | 2007-04-16 | 2015-10-20 | Occlutech Holding Ag | Occluder for occluding an atrial appendage and production process therefor |
US9826980B2 (en) * | 2007-04-16 | 2017-11-28 | Occlutech Holding Ag | Occluder for occluding an atrial appendage and production process therefor |
US20160015397A1 (en) * | 2007-04-16 | 2016-01-21 | Occlutech Holding Ag | Occluder For Occluding An Atrial Appendage And Production Process Therefor |
US9023094B2 (en) | 2007-06-25 | 2015-05-05 | Microvention, Inc. | Self-expanding prosthesis |
US8747453B2 (en) | 2008-02-18 | 2014-06-10 | Aga Medical Corporation | Stent/stent graft for reinforcement of vascular abnormalities and associated method |
US8142456B2 (en) | 2008-04-21 | 2012-03-27 | Nfocus Neuromedical, Inc. | Braid-ball embolic devices |
US9039726B2 (en) | 2008-04-21 | 2015-05-26 | Covidien Lp | Filamentary devices for treatment of vascular defects |
US8747597B2 (en) | 2008-04-21 | 2014-06-10 | Covidien Lp | Methods for making braid-ball occlusion devices |
US11844528B2 (en) * | 2008-04-21 | 2023-12-19 | Covidien Lp | Multiple layer filamentary devices for treatment of vascular defects |
US9585669B2 (en) | 2008-04-21 | 2017-03-07 | Covidien Lp | Multiple layer filamentary devices for treatment of vascular defects |
US8696701B2 (en) | 2008-04-21 | 2014-04-15 | Covidien Lp | Braid-ball embolic devices |
US20220022886A1 (en) * | 2008-04-21 | 2022-01-27 | Covidien Lp | Multiple layer filamentary devices for treatment of vascular defects |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US8974487B2 (en) | 2008-05-01 | 2015-03-10 | Aneuclose Llc | Aneurysm occlusion device |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US20200100795A1 (en) * | 2008-05-01 | 2020-04-02 | Aneuclose Llc | "Bowl-of-Spaghetti" Type Intrasacular Aneurysm Occlusion Device |
US11707371B2 (en) | 2008-05-13 | 2023-07-25 | Covidien Lp | Braid implant delivery systems |
US9675482B2 (en) | 2008-05-13 | 2017-06-13 | Covidien Lp | Braid implant delivery systems |
US10610389B2 (en) | 2008-05-13 | 2020-04-07 | Covidien Lp | Braid implant delivery systems |
US9179918B2 (en) | 2008-07-22 | 2015-11-10 | Covidien Lp | Vascular remodeling device |
US11185333B2 (en) | 2008-09-05 | 2021-11-30 | Pulsar Vascular, Inc. | Systems and methods for supporting or occluding a physiological opening or cavity |
US9615831B2 (en) | 2008-09-05 | 2017-04-11 | Pulsar Vascular, Inc. | Systems and methods for supporting or occluding a physiological opening or cavity |
US8388650B2 (en) | 2008-09-05 | 2013-03-05 | Pulsar Vascular, Inc. | Systems and methods for supporting or occluding a physiological opening or cavity |
US8979893B2 (en) | 2008-09-05 | 2015-03-17 | Pulsar Vascular, Inc. | Systems and methods for supporting or occluding a physiological opening or cavity |
US10285709B2 (en) | 2008-09-05 | 2019-05-14 | Pulsar Vascular, Inc. | Systems and methods for supporting or occluding a physiological opening or cavity |
US8636760B2 (en) | 2009-04-20 | 2014-01-28 | Covidien Lp | System and method for delivering and deploying an occluding device within a vessel |
US11633189B2 (en) | 2009-09-04 | 2023-04-25 | Pulsar Vascular, Inc. | Systems and methods for enclosing an anatomical opening |
US10335153B2 (en) | 2009-09-04 | 2019-07-02 | Pulsar Vascular, Inc. | Systems and methods for enclosing an anatomical opening |
US9277924B2 (en) | 2009-09-04 | 2016-03-08 | Pulsar Vascular, Inc. | Systems and methods for enclosing an anatomical opening |
US9095342B2 (en) | 2009-11-09 | 2015-08-04 | Covidien Lp | Braid ball embolic device features |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
US8906057B2 (en) | 2010-01-04 | 2014-12-09 | Aneuclose Llc | Aneurysm embolization by rotational accumulation of mass |
US8926681B2 (en) | 2010-01-28 | 2015-01-06 | Covidien Lp | Vascular remodeling device |
US9468442B2 (en) | 2010-01-28 | 2016-10-18 | Covidien Lp | Vascular remodeling device |
US8425548B2 (en) | 2010-07-01 | 2013-04-23 | Aneaclose LLC | Occluding member expansion and then stent expansion for aneurysm treatment |
US9351859B2 (en) | 2010-12-06 | 2016-05-31 | Covidien Lp | Vascular remodeling device |
US9610180B2 (en) | 2010-12-06 | 2017-04-04 | Covidien Lp | Vascular remodeling device |
US9393022B2 (en) | 2011-02-11 | 2016-07-19 | Covidien Lp | Two-stage deployment aneurysm embolization devices |
US9089332B2 (en) | 2011-03-25 | 2015-07-28 | Covidien Lp | Vascular remodeling device |
US10004511B2 (en) | 2011-03-25 | 2018-06-26 | Covidien Lp | Vascular remodeling device |
US11147563B2 (en) | 2011-03-25 | 2021-10-19 | Covidien Lp | Vascular remodeling device |
US11284903B2 (en) | 2011-03-30 | 2022-03-29 | Hesham Morsi | Advanced endovascular clip and method of using same |
US10028745B2 (en) | 2011-03-30 | 2018-07-24 | Noha, Llc | Advanced endovascular clip and method of using same |
US10959735B2 (en) | 2011-03-30 | 2021-03-30 | Noha, Llc | Advanced endovascular clip and method of using same |
US9138232B2 (en) | 2011-05-24 | 2015-09-22 | Aneuclose Llc | Aneurysm occlusion by rotational dispensation of mass |
WO2012163880A1 (fr) * | 2011-05-31 | 2012-12-06 | Acandis Gmbh & Co. Kg | Implant médical à disposer à l'intérieur d'un corps creux, en particulier d'un anévrisme, et procédé de fabrication d'un implant médical |
US10624647B2 (en) | 2011-06-03 | 2020-04-21 | Pulsar Vascular, Inc. | Aneurysm devices with additional anchoring mechanisms and associated systems and methods |
US10004510B2 (en) | 2011-06-03 | 2018-06-26 | Pulsar Vascular, Inc. | Systems and methods for enclosing an anatomical opening, including shock absorbing aneurysm devices |
US11344311B2 (en) | 2011-06-03 | 2022-05-31 | Pulsar Vascular, Inc. | Aneurysm devices with additional anchoring mechanisms and associated systems and methods |
US10828182B2 (en) | 2011-09-29 | 2020-11-10 | Covidien Lp | Vascular remodeling device |
US11654037B2 (en) | 2011-09-29 | 2023-05-23 | Covidien Lp | Vascular remodeling device |
US9060886B2 (en) | 2011-09-29 | 2015-06-23 | Covidien Lp | Vascular remodeling device |
US10426487B2 (en) | 2011-10-05 | 2019-10-01 | Pulsar Vascular, Inc. | Devices, systems and methods for enclosing an anatomical opening |
US11457923B2 (en) | 2011-10-05 | 2022-10-04 | Pulsar Vascular, Inc. | Devices, systems and methods for enclosing an anatomical opening |
US9636117B2 (en) | 2011-10-05 | 2017-05-02 | Pulsar Vascular, Inc. | Devices, systems and methods for enclosing an anatomical opening |
US9119625B2 (en) | 2011-10-05 | 2015-09-01 | Pulsar Vascular, Inc. | Devices, systems and methods for enclosing an anatomical opening |
US20140350588A1 (en) * | 2011-11-09 | 2014-11-27 | Easynotes Ltd. | Obstruction device |
US10219931B2 (en) * | 2011-11-09 | 2019-03-05 | Easynotes Ltd. | Obstruction device |
US9259229B2 (en) | 2012-05-10 | 2016-02-16 | Pulsar Vascular, Inc. | Systems and methods for enclosing an anatomical opening, including coil-tipped aneurysm devices |
US9877856B2 (en) | 2012-07-18 | 2018-01-30 | Covidien Lp | Methods and apparatus for luminal stenting |
US9155647B2 (en) | 2012-07-18 | 2015-10-13 | Covidien Lp | Methods and apparatus for luminal stenting |
US9962164B2 (en) | 2012-10-31 | 2018-05-08 | Covidien Lp | Wing bifurcation reconstruction device |
US9186267B2 (en) | 2012-10-31 | 2015-11-17 | Covidien Lp | Wing bifurcation reconstruction device |
US9924959B2 (en) | 2012-11-06 | 2018-03-27 | Covidien Lp | Multi-pivot thrombectomy device |
US9314248B2 (en) | 2012-11-06 | 2016-04-19 | Covidien Lp | Multi-pivot thrombectomy device |
US11406405B2 (en) | 2012-11-06 | 2022-08-09 | Covidien Lp | Multi-pivot thrombectomy device |
US11786253B2 (en) * | 2012-11-13 | 2023-10-17 | Covidien Lp | Occlusive devices |
US20190343532A1 (en) * | 2012-11-13 | 2019-11-14 | Covidien Lp | Occlusive devices |
US10327781B2 (en) | 2012-11-13 | 2019-06-25 | Covidien Lp | Occlusive devices |
US11690628B2 (en) | 2012-11-13 | 2023-07-04 | Covidien Lp | Occlusive devices |
US9295571B2 (en) | 2013-01-17 | 2016-03-29 | Covidien Lp | Methods and apparatus for luminal stenting |
US9901472B2 (en) | 2013-01-17 | 2018-02-27 | Covidien Lp | Methods and apparatus for luminal stenting |
WO2014128313A1 (fr) * | 2013-02-21 | 2014-08-28 | Castaño Duque Carlos | Dispositif de support et de placement d'éléments occlusifs |
US10716549B2 (en) | 2013-03-05 | 2020-07-21 | St. Jude Medical, Cardiology Division, Inc. | Medical device for treating a target site |
WO2014137467A1 (fr) * | 2013-03-05 | 2014-09-12 | Aga Medical Corporation | Dispositif médical pour traiter un site cible |
US20170252045A1 (en) * | 2013-03-13 | 2017-09-07 | Lawrence Livermore National Security, Llc | Shape-memory polymer foam device for treating aneurysms |
US11141164B2 (en) * | 2013-03-13 | 2021-10-12 | Lawrence Livermore National Security, Llc | Shape-memory polymer foam device for treating aneurysms |
US9463105B2 (en) | 2013-03-14 | 2016-10-11 | Covidien Lp | Methods and apparatus for luminal stenting |
US20160213459A1 (en) * | 2013-03-15 | 2016-07-28 | Insera Therapeutics, Inc. | Vascular treatment devices and methods |
US10736758B2 (en) | 2013-03-15 | 2020-08-11 | Covidien | Occlusive device |
US10342655B2 (en) | 2013-03-15 | 2019-07-09 | Insera Therapeutics, Inc. | Methods of treating a thrombus in an artery using cyclical aspiration patterns |
US10335260B2 (en) | 2013-03-15 | 2019-07-02 | Insera Therapeutics, Inc. | Methods of treating a thrombus in a vein using cyclical aspiration patterns |
US11389309B2 (en) | 2013-03-15 | 2022-07-19 | Covidien Lp | Occlusive device |
US11298144B2 (en) | 2013-03-15 | 2022-04-12 | Insera Therapeutics, Inc. | Thrombus aspiration facilitation systems |
US10463468B2 (en) | 2013-03-15 | 2019-11-05 | Insera Therapeutics, Inc. | Thrombus aspiration with different intensity levels |
US10251739B2 (en) | 2013-03-15 | 2019-04-09 | Insera Therapeutics, Inc. | Thrombus aspiration using an operator-selectable suction pattern |
US9901435B2 (en) * | 2013-03-15 | 2018-02-27 | Insera Therapeutics, Inc. | Longitudinally variable vascular treatment devices |
US10390926B2 (en) | 2013-07-29 | 2019-08-27 | Insera Therapeutics, Inc. | Aspiration devices and methods |
US10751159B2 (en) | 2013-07-29 | 2020-08-25 | Insera Therapeutics, Inc. | Systems for aspirating thrombus during neurosurgical procedures |
US11154302B2 (en) | 2014-03-31 | 2021-10-26 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US11076860B2 (en) | 2014-03-31 | 2021-08-03 | DePuy Synthes Products, Inc. | Aneurysm occlusion device |
US10130372B2 (en) | 2014-04-30 | 2018-11-20 | Cerus Endovascular Limited | Occlusion Device |
US12029431B2 (en) | 2014-04-30 | 2024-07-09 | Stryker Ireland Technology, Ltd. | Occlusion device |
EP3970635A1 (fr) | 2014-04-30 | 2022-03-23 | Cerus Endovascular Limited | Appareil d'occlusion |
WO2015166013A1 (fr) | 2014-04-30 | 2015-11-05 | Cerus Endovascular Limited | Dispositif d'occlusion |
EP3510945A1 (fr) | 2014-04-30 | 2019-07-17 | Cerus Endovascular Limited | Dispositif d'occlusion |
US11389174B2 (en) | 2014-04-30 | 2022-07-19 | Cerus Endovascular Limited | Occlusion device |
US11284901B2 (en) | 2014-04-30 | 2022-03-29 | Cerus Endovascular Limited | Occlusion device |
CN114391910A (zh) * | 2014-12-31 | 2022-04-26 | 先健科技(深圳)有限公司 | 左心耳封堵器 |
US20180333158A1 (en) * | 2015-02-25 | 2018-11-22 | Galaxy Therapeutics, Llc | System for and method of treating aneurysms |
US10856879B2 (en) * | 2015-02-25 | 2020-12-08 | Galaxy Therapeutics Inc. | System for and method of treating aneurysms |
US11883032B2 (en) | 2015-02-25 | 2024-01-30 | Galaxy Therapeutics, Inc. | System for and method of treating aneurysms |
US10265078B2 (en) | 2015-04-01 | 2019-04-23 | Boston Scientific Scimed, Inc. | Systems and methods for delivery of gel embolics |
WO2016161344A1 (fr) * | 2015-04-01 | 2016-10-06 | Boston Scientific Scimed, Inc. | Systèmes et procédés d'administration d'emboliques en gel |
US11877753B2 (en) | 2015-04-01 | 2024-01-23 | Boston Scientific Scimed, Inc. | Systems and methods for delivery of gel embolics |
EP4299019A3 (fr) * | 2015-04-01 | 2024-03-06 | Boston Scientific Scimed, Inc. | Systèmes d'administration d'emboliques en gel |
CN105105812A (zh) * | 2015-09-18 | 2015-12-02 | 王奎重 | 一种颅内动脉瘤介入栓塞治疗装置 |
US11357510B2 (en) | 2015-09-23 | 2022-06-14 | Covidien Lp | Occlusive devices |
US10478194B2 (en) | 2015-09-23 | 2019-11-19 | Covidien Lp | Occlusive devices |
US11471162B2 (en) | 2015-12-07 | 2022-10-18 | Cerus Endovascular Limited | Occlusion device |
US11648013B2 (en) | 2016-03-11 | 2023-05-16 | Cerus Endovascular Limited | Occlusion device |
US10869672B2 (en) | 2016-03-11 | 2020-12-22 | Cents Endovascular Limited | Occlusion device |
WO2017153603A1 (fr) | 2016-03-11 | 2017-09-14 | Cerus Endovascular Limited | Dispositif d'occlusion |
EP3782576A1 (fr) | 2016-03-11 | 2021-02-24 | Cerus Endovascular Limited | Dispositif d'occlusion |
US10555738B2 (en) | 2016-05-18 | 2020-02-11 | Microvention, Inc. | Embolic containment |
US10898203B2 (en) | 2016-05-18 | 2021-01-26 | Microvention, Inc. | Embolic containment |
US11484323B2 (en) | 2016-05-18 | 2022-11-01 | Microvention, Inc. | Embolic containment |
WO2017201316A1 (fr) * | 2016-05-18 | 2017-11-23 | Microvention, Inc. | Confinement embolique |
CN113180882A (zh) * | 2016-06-21 | 2021-07-30 | 内流医疗有限公司 | 用于治疗血管畸形部的装置及试剂盒 |
US20190374232A1 (en) * | 2017-02-23 | 2019-12-12 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US20180242979A1 (en) * | 2017-02-23 | 2018-08-30 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11890020B2 (en) | 2017-02-23 | 2024-02-06 | DePuy Synthes Products, Inc. | Intrasaccular aneurysm treatment device with varying coatings |
US11672543B2 (en) | 2017-02-23 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm method and system |
US10743884B2 (en) * | 2017-02-23 | 2020-08-18 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10751066B2 (en) * | 2017-02-23 | 2020-08-25 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11812971B2 (en) | 2017-08-21 | 2023-11-14 | Cerus Endovascular Limited | Occlusion device |
CN111031938A (zh) * | 2017-08-22 | 2020-04-17 | 柯惠有限合伙公司 | 用于治疗血管缺损的装置、***和方法 |
US11185335B2 (en) * | 2018-01-19 | 2021-11-30 | Galaxy Therapeutics Inc. | System for and method of treating aneurysms |
US20190223876A1 (en) * | 2018-01-19 | 2019-07-25 | Galaxy Therapeutics, Llc | System for and method of treating aneurysms |
US11672540B2 (en) | 2018-01-24 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10905430B2 (en) | 2018-01-24 | 2021-02-02 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11596412B2 (en) | 2018-05-25 | 2023-03-07 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11058430B2 (en) * | 2018-05-25 | 2021-07-13 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US10939915B2 (en) | 2018-05-31 | 2021-03-09 | DePuy Synthes Products, Inc. | Aneurysm device and delivery system |
US11583288B2 (en) | 2018-08-08 | 2023-02-21 | DePuy Synthes Products, Inc. | Delivery of embolic braid |
US11123077B2 (en) | 2018-09-25 | 2021-09-21 | DePuy Synthes Products, Inc. | Intrasaccular device positioning and deployment system |
US11076861B2 (en) * | 2018-10-12 | 2021-08-03 | DePuy Synthes Products, Inc. | Folded aneurysm treatment device and delivery method |
US11633191B2 (en) | 2018-10-12 | 2023-04-25 | DePuy Synthes Products, Inc. | Folded aneurysm treatment device and delivery method |
US11406392B2 (en) | 2018-12-12 | 2022-08-09 | DePuy Synthes Products, Inc. | Aneurysm occluding device for use with coagulating agents |
US11272939B2 (en) * | 2018-12-18 | 2022-03-15 | DePuy Synthes Products, Inc. | Intrasaccular flow diverter for treating cerebral aneurysms |
US11134953B2 (en) | 2019-02-06 | 2021-10-05 | DePuy Synthes Products, Inc. | Adhesive cover occluding device for aneurysm treatment |
US11337706B2 (en) | 2019-03-27 | 2022-05-24 | DePuy Synthes Products, Inc. | Aneurysm treatment device |
US11607226B2 (en) | 2019-05-21 | 2023-03-21 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device with corrugations |
US11278292B2 (en) | 2019-05-21 | 2022-03-22 | DePuy Synthes Products, Inc. | Inverting braided aneurysm treatment system and method |
US11583282B2 (en) | 2019-05-21 | 2023-02-21 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US10653425B1 (en) | 2019-05-21 | 2020-05-19 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11672542B2 (en) | 2019-05-21 | 2023-06-13 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable ball segment |
US11497504B2 (en) | 2019-05-21 | 2022-11-15 | DePuy Synthes Products, Inc. | Aneurysm treatment with pushable implanted braid |
US11413046B2 (en) | 2019-05-21 | 2022-08-16 | DePuy Synthes Products, Inc. | Layered braided aneurysm treatment device |
US11622771B2 (en) | 2019-05-25 | 2023-04-11 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US11969171B2 (en) | 2019-05-25 | 2024-04-30 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US11166731B2 (en) | 2019-05-25 | 2021-11-09 | Galaxy Therapeutics Inc. | Systems and methods for treating aneurysms |
US11974754B2 (en) | 2019-05-25 | 2024-05-07 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US11058431B2 (en) | 2019-05-25 | 2021-07-13 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US10856880B1 (en) | 2019-05-25 | 2020-12-08 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US11033277B2 (en) | 2019-05-25 | 2021-06-15 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
US11202636B2 (en) | 2019-05-25 | 2021-12-21 | Galaxy Therapeutics Inc. | Systems and methods for treating aneurysms |
US11633818B2 (en) | 2019-11-04 | 2023-04-25 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
US11685007B2 (en) | 2019-11-04 | 2023-06-27 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
US11717924B2 (en) | 2019-11-04 | 2023-08-08 | Covidien Lp | Devices, systems, and methods for treatment of intracranial aneurysms |
US11679458B2 (en) | 2019-11-04 | 2023-06-20 | Covidien Lp | Devices, systems, and methods for treating aneurysms |
US11602350B2 (en) | 2019-12-05 | 2023-03-14 | DePuy Synthes Products, Inc. | Intrasaccular inverting braid with highly flexible fill material |
US11457926B2 (en) | 2019-12-18 | 2022-10-04 | DePuy Synthes Products, Inc. | Implant having an intrasaccular section and intravascular section |
WO2021130064A3 (fr) * | 2019-12-23 | 2021-08-19 | Phenox Gmbh | Implant pour traiter des anévrismes |
US11406404B2 (en) | 2020-02-20 | 2022-08-09 | Cerus Endovascular Limited | Clot removal distal protection methods |
US12042151B2 (en) * | 2020-09-15 | 2024-07-23 | Stryker Corporation and Stryker European Operations Holdings LLC | Intra-aneurysm devices |
US11986189B2 (en) | 2021-01-27 | 2024-05-21 | Galaxy Therapeutics, Inc. | Systems and methods for treating aneurysms |
CN116687496A (zh) * | 2023-08-04 | 2023-09-05 | 北京久事神康医疗科技有限公司 | 一种带网盘的栓塞装置 |
Also Published As
Publication number | Publication date |
---|---|
US20110196413A1 (en) | 2011-08-11 |
EP1494619A1 (fr) | 2005-01-12 |
CA2481224C (fr) | 2010-12-21 |
US9314326B2 (en) | 2016-04-19 |
WO2003086240A1 (fr) | 2003-10-23 |
JP2005522266A (ja) | 2005-07-28 |
US20070106311A1 (en) | 2007-05-10 |
CA2481224A1 (fr) | 2003-10-23 |
ATE439092T1 (de) | 2009-08-15 |
DE60328765D1 (de) | 2009-09-24 |
EP1494619B1 (fr) | 2009-08-12 |
ES2331567T3 (es) | 2010-01-08 |
JP4414767B2 (ja) | 2010-02-10 |
AU2003224913A1 (en) | 2003-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9314326B2 (en) | System and method for retaining vaso-occlusive devices within an aneurysm | |
US20200000477A1 (en) | Embolization Plug | |
US11076860B2 (en) | Aneurysm occlusion device | |
US6036720A (en) | Sheet metal aneurysm neck bridge | |
EP1109499B1 (fr) | Piece de fermeture detachable pour collet anevrysmal | |
US11154302B2 (en) | Aneurysm occlusion device | |
JP6719963B2 (ja) | リードフレームコイルを有する膨張性血管閉塞器具 | |
US6193708B1 (en) | Detachable aneurysm neck bridge (I) | |
US20170035430A1 (en) | Devices and Methods for Treatment of Endovascular and Non-Endovascular Defects in Humans Using Occlusion Implants | |
EP3622901A1 (fr) | Dispositif d'occlusion d'anévrisme | |
US20180221030A1 (en) | Devices and Methods for Treatment of Endovascular and Non-Endovascular Defects in Humans Using Tandem Embolization Devices | |
US20180317933A1 (en) | Devices and Methods for Treatment of Endovascular and Non-Endovascular Defects in Humans | |
JPH1071154A (ja) | 動脈瘤閉鎖デバイスアセンブリ | |
JP2003524433A (ja) | 迅速脱着する電気的に絶縁されたインプラント | |
KR102359744B1 (ko) | 가요성 분리 영역을 이용하는 혈관용 이식 시스템 및 혈관용 이식 프로세스 | |
WO2020139544A2 (fr) | Dispositif de réduction de flux intra-sacculaire multi-couche conformable et ses procédés de fabrication | |
CN115670566A (zh) | 用于血管阻塞的相关***和方法 | |
WO2024035592A1 (fr) | Dispositifs d'administration pour le traitement de défauts vasculaires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TARGET THERAPEUTICS, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:WALLACE, MICHAEL;EDER, JOSEPH;GERBERDING, BRENT;REEL/FRAME:012812/0175 Effective date: 20020411 |
|
AS | Assignment |
Owner name: BOSTON SCIENTIFIC SCIMED, INC. (FORMERLY SCIMED LI Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE PREVIOUSLY RECORDED ON REEL 012812 FRAME 0175;ASSIGNORS:WALLACE, MICHAEL;EDER, JOSEPH;GERBERDING, BRENT;REEL/FRAME:018863/0279 Effective date: 20020411 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: STRYKER NV OPERATIONS LIMITED, IRELAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:026162/0967 Effective date: 20110103 Owner name: STRYKER CORPORATION, MICHIGAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:026162/0967 Effective date: 20110103 |
|
AS | Assignment |
Owner name: STRYKER MEDTECH LIMITED, MALTA Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:037153/0034 Effective date: 20151013 Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:037153/0241 Effective date: 20151013 |
|
AS | Assignment |
Owner name: STRYKER CORPORATION, MICHIGAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:037156/0607 Effective date: 20110103 Owner name: STRYKER NV OPERATIONS LIMITED, IRELAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:037156/0607 Effective date: 20110103 |
|
AS | Assignment |
Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:038043/0011 Effective date: 20151013 Owner name: STRYKER MEDTECH LIMITED, MALTA Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:038039/0001 Effective date: 20151013 |
|
AS | Assignment |
Owner name: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC, MICHIGAN Free format text: CHANGE OF NAME;ASSIGNOR:STRYKER EUROPEAN HOLDINGS III, LLC;REEL/FRAME:052860/0716 Effective date: 20190226 Owner name: STRYKER EUROPEAN HOLDINGS III, LLC, DELAWARE Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER EUROPEAN HOLDINGS I, LLC;REEL/FRAME:052861/0001 Effective date: 20200519 |